PHC Corporation of North America (PHCNA) is set to introduce its LiCellGrow Cell Expansion System prototype at Advanced Therapies Week in January. This innovative system simplifies and optimizes cell culture processes for cell and gene therapy (CGT) production, addressing key challenges faced by lab managers in pharmaceutical and research labs.
Streamlining cell culture processes
The LiCellGrow system features In-Line monitoring technology, enabling automated, real-time tracking of glucose and lactate levels—critical indicators of cell metabolism. By eliminating manual sampling and maintaining optimal cell growth conditions, the system improves cell culture efficiency and reduces production downtime.
Why lab managers need LiCellGrow
Lab managers in CGT production often face challenges such as maintaining consistent cell quality, minimizing contamination risks, and optimizing workflows. LiCellGrow addresses these issues with:
- Automated Media Exchange for continuous optimization.
- Closed-System Cell Culturing with sterile, single-use culture bags.
- Reduced Manual Intervention for improved productivity.
- Compatibility with Existing Equipment for seamless integration.
By automating key steps in the cell culture process, LiCellGrow improves reliability, minimizes costs, and allows lab teams to focus on other critical tasks.
Enhanced efficiency and quality control
The system ensures stable and reproducible cell culture environments, reducing variability and enhancing CGT product consistency. Its closed-system design minimizes the risk of contamination, a key concern for labs producing patient-specific therapies.
Conclusion
PHCNA's LiCellGrow system combines cutting-edge sensor technology with automated control to meet the growing demand for efficient CGT manufacturing. Lab managers can look forward to streamlined workflows, enhanced cell quality, and reduced operational costs—all critical for today’s fast-paced research and pharmaceutical environments.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit PHC Corporation of North America
